Katie Greenzang

Clinical Interests

• Medical education
• Pediatric oncology
• Survivorship

Recent Awards:

• Children's Cancer Research Fund, Survivorship Award, 2022
• National Institutes of Health (NIH) Mentored Clinical Scientist Research Career Development Award, (K08), 2019
• St. Baldrick's Foundation Career Development Scholar Award, 2019
• Career Development Award (CDA), Conquer Cancer, The American Society of Clinical Oncology (ASCO) Foundation, 2019

Publications from Harvard Catalyst Profiles

• Weaver MS, Jacobs SS, Withycombe JS, Wang J, Greenzang KA, Baker JN, Hinds PS. Profile Comparison of Patient-Reported and Proxy-Reported Symptoms in Pediatric Patients With Cancer Receiving Chemotherapy. JAMA Netw Open 2022; 5:e221855. PubMed
• Carpenter K, Scavotto M, McGovern A, Ma C, Kenney LB, Mack JW, Greenzang KA. Early parental knowledge of late effect risks in children with cancer. Pediatr Blood Cancer 2022; 69:e29473. PubMed
• Greenzang KA, Kelly CA, Al-Sayegh H, Ma C, Mack JW. Thinking ahead: Parents' worries about late effects of childhood cancer treatment. Pediatr Blood Cancer 2021; 68:e29335. PubMed
• Weaver MS, Wang J, Greenzang KA, McFatrich M, Hinds PS. The predictive trifecta? Fatigue, pain, and anxiety severity forecast the suffering profile of children with cancer. Support Care Cancer 2021. PubMed
• Brand McCarthy S, Tarquini SJ, Metcalf B, Lucy Pickard, Greenzang KA, Mack J. "What Matters to Me": What pediatric stem cell transplant patients want their providers to know. J Psychosoc Oncol 2021. PubMed
• Liu KX, Collins NB, Greenzang KA, Furutani E, Campbell K, Groves A, Mullen EA, Shusterman S, Spidle J, Marcus KJ, Weil BR, Weldon CB, Frazier AL, Janeway KA, O'Neill AF, Mack JW, DuBois SG, Shulman DS. The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatr Blood Cancer 2020. PubMed
• Greenzang KA, Fasciano KM, Block SD, Mack JW. Early information needs of adolescents and young adults about late effects of cancer treatment. Cancer 2020; 126:3281-3288. PubMed
• Greenzang KA, Al-Sayegh H, Ma C, Najafzadeh M, Wittenberg E, Mack JW. Parental Considerations Regarding Cure and Late Effects for Children With Cancer. Pediatrics 2020. PubMed
• Lin B, Gutman T, Hanson CS, Ju A, Manera K, Butow P, Cohn RJ, Dalla-Pozza L, Greenzang KA, Mack J, Wakefield CE, Craig JC, Tong A. Communication during childhood cancer: Systematic review of patient perspectives. Cancer 2019. PubMed
• Perez S, Greenzang KA. Completion of Adolescent Cancer Treatment: Excitement, Guilt, and Anxiety. Pediatrics 2019. PubMed
• Greenzang KA, Cronin AM, Kang TI, Mack JW. Parental distress and desire for information regarding long-term implications of pediatric cancer treatment. Cancer 2018. PubMed
• Greenzang KA, Cronin AM, Kang T, Mack JW. Parent understanding of the risk of future limitations secondary to pediatric cancer treatment. Pediatr Blood Cancer 2018. PubMed
• Greenzang KA, Dauti A, Mack JW. Parent perspectives on information about late effects of childhood cancer treatment and their role in initial treatment decision making. Pediatr Blood Cancer 2018. PubMed
• Greenzang KA, Cronin AM, Mack JW. Parental preparedness for late effects and long-term quality of life in survivors of childhood cancer. Cancer 2016. PubMed